Person

Michael S. Cuffe

EVP and Chief Clinical Officer, HCA Healthcare

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$30.3M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 3, 2026HCASale1,500$498.09$747K
Sep 8, 2025HCASale3,836$418.84$1.6M
Sep 12, 2024HCASale8,358$385.42$3.2M
May 9, 2024HCASale6,311$316.88$2.0M
May 6, 2024HCASale1,600$309.00$494K
Jan 31, 2024HCASale3,200$306.79$982K
Apr 28, 2023HCASale12,556$284.44$3.6M
Feb 1, 2023HCASale4,000$257.11$1.0M
Aug 3, 2021HCASale2,500$251.91$630K
Apr 29, 2021HCASale18,664$201.53$3.8M
Feb 5, 2021HCASale13,718$176.22$2.4M
Feb 3, 2021HCASale7,574$171.17$1.3M
Feb 5, 2020HCASale6,459$150.00$969K
Dec 23, 2019HCASale5,891$147.04$866K
Nov 9, 2018HCASale4,943$141.90$701K
Nov 2, 2018HCASale5,196$136.52$709K
Jul 30, 2018HCASale5,313$125.26$666K
Feb 9, 2018HCASale8,335$97.26$811K
Dec 15, 2017HCASale2,400$86.63$208K
Nov 22, 2017HCASale2,150$78.00$168K
Oct 17, 2017HCASale2,150$78.00$168K
Sep 15, 2017HCASale2,150$79.87$172K
Aug 15, 2017HCASale2,150$79.88$172K
Jul 17, 2017HCASale2,150$86.44$186K
Jun 15, 2017HCASale2,150$84.86$182K
May 15, 2017HCASale2,150$84.52$182K
Apr 17, 2017HCASale2,150$85.00$183K
Mar 15, 2017HCASale2,150$84.10$181K
Feb 15, 2017HCASale2,150$83.75$180K
Jan 17, 2017HCASale2,150$80.00$172K
Jan 9, 2017HCASale4,300$78.00$335K
Oct 28, 2016HCASale2,150$79.41$171K
May 24, 2016HCASale2,575$76.20$196K
Apr 25, 2016HCASale2,575$80.73$208K
Mar 24, 2016HCASale2,575$76.19$196K
Feb 24, 2016HCASale2,575$70.00$180K
Jan 28, 2016HCASale5,150$70.00$361K

SEC reporting-owner ID (CIK) 1632835 · all filings on EDGAR

Michael S. Cuffe (HCA) | USBoard